Indocyanine Green

[06 August 2014]

Products Affected - Description

IC Green, Akorn
25 mg kit (NDC 17478-0701-02)

Indocyanine Green, Hub Pharmaceuticals
25 mg vial (NDC 25431-0424-02)

Reason for the Shortage

  • Akorn states the reason for the shortage is increased demand.
  • Hub Pharmaceuticals cannot provide a reason for the shortage.

Available Products

No presentations are available.

Estimated Resupply Dates

  • Akorn has IC Green on back order and the company estimates a release date in late-August 2014. Check with your wholesaler for availability.
  • Hub Pharmaceuticals has indocyanine green on back order and the company cannot estimate a release date.

Related Shortages


August 6, 2014; July 3, 2014; June 12, 2014; May 22, 2014, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.